Evidence map›Paper›PMID 33195653›Full record

ArticleWorld journal of clinical cases2020

End-of-life home care of an interstitial pneumonia patient supported by high-flow nasal cannula therapy: A case report.

Ken Goda, Tsuneaki Kenzaka, Kyosuke Kuriyama, Masahiko Hoshijima, Hozuka Akita

Open access · diamondAbstract readCase Reports
In one paragraph

Article in World journal of clinical cases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Ken GodaDepartment of Internal Medicine, Hyogo Prefectural Tamba Medical Center, Tamba 669-3495, Japan.
Tsuneaki KenzakaDepartment of Internal Medicine, Hyogo Prefectural Tamba Medical Center, Tamba 669-3495, Japan.
Kyosuke KuriyamaClinical Engineer, Nursing Department, Hyogo Prefectural Tamba Medical Center, Tamba 669-3495, Japan.
Masahiko HoshijimaDepartment of Internal Medicine, Hyogo Prefectural Tamba Medical Center, Tamba 669-3495, Japan.
Hozuka AkitaDepartment of Internal Medicine, Hyogo Prefectural Tamba Medical Center, Tamba 669-3495, Japan.
Tokyo Metropolitan Tama-Hokubu Medical Center · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHigh-flow nasal cannula (HFNC) therapy and morphine continuous subcutaneous infusion (CSI) have been used to ameliorate dyspnea in non-cancer patients with end-stage respiratory diseases, including chronic obstructive pulmonary disease and interstitial pneumonia, primarily in hospital settings. However, it is rare to perform home-based medical treatment using these. We observe a case to assess the feasibility of this treatment strategy. CASE SUMMARY: Here, we report a case of a 75-year-old man who was diagnosed with interstitial pneumonia 11 years ago and was successfully nursed at home during his terminal phase for over 10 mo without hospitalization, by introducing domiciliary uses of HFNC and morphine CSI with a patient-controlled analgesia device.

conclusionActive utilization of HFNC and morphine CSI with patient-controlled analgesia device would substantiate successful end-of-life palliative home care of idiopathic interstitial pneumonia patients.

Indexed as

Case reportContinuous subcutaneous infusionHigh flow nasal cannulaHome careInterstitial pneumoniaMorphinePatient controlled analgesia

Identifiers

PMID33195653
PMCPMC7642529
OpenAlexW3095953541

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.